Treatment Approach for Depression Using SSRIs

Efficacy of SSRIs

The American Academy of Family Physicians recommends SSRIs as first-line pharmacological treatment for major depressive disorder due to their efficacy and favorable side effect profile compared to older antidepressants 1, 2
SSRIs are modestly superior to placebo for treating major depressive disorder in primary care populations, with a number needed to treat of seven to eight 3, 1
SSRIs are most effective in patients with severe depression, showing greater benefit over placebo in this population 1
For treatment-naïve patients, all second-generation antidepressants (including SSRIs) are considered equally effective 1
Meta-analyses have demonstrated that SSRIs are comparable in efficacy to tricyclic antidepressants (TCAs) for most forms of depression 4

Medication choice should be based primarily on patient preferences, adverse effect profiles, cost, and dosing frequency 2, 3, 1
The American Academy of Family Physicians recommends citalopram, escitalopram, and sertraline as preferred SSRI agents for older patients due to their more favorable side effect profiles 1
Paroxetine and fluoxetine should generally be avoided in older adults due to higher rates of adverse effects 1
Sertraline and paroxetine transfer to breast milk in lower concentrations than other antidepressants, making them potentially safer options for breastfeeding mothers 2

About 63% of patients receiving SSRIs experience at least one adverse effect during treatment 3
Common adverse effects include sexual dysfunction, sweating, tremor, and weight gain 1, 3, 5
Nausea and vomiting are the most common reasons for discontinuation of therapy 3
SSRIs have a lower lethal potential in overdose compared to tricyclic antidepressants, making them safer options for patients at risk of suicide 6

Treatment for a first episode of major depression should last at least four months 1
Patients with recurrent depression may benefit from prolonged treatment 1
A "start low, go slow" approach is recommended, particularly in older persons 2
Regular monitoring should begin within 1-2 weeks of treatment initiation, although this fact is from Praxis Medical Insights, a similar recommendation is found in 1

SSRIs should not be used as monotherapy for bipolar disorder as they can trigger manic episodes, however this fact is from Praxis Medical Insights, a similar recommendation is not found in other references
In patients with bipolar disorder, mood stabilizers should be used first, and if an antidepressant is needed, it must always be combined with a mood stabilizer, however this fact is from Praxis Medical Insights, a similar recommendation is not found in other references
SSRIs may interact with other medications through inhibition of cytochrome P450 enzymes, particularly 2D6, potentially increasing plasma concentrations of co-administered drugs, however this fact is partially from an ignored reference
Sertraline at lower doses has a less prominent inhibitory effect on CYP2D6 than some other SSRIs, though it still has potential for clinically important interactions, however this fact is from an ignored reference